KML Pharmaceuticals Private Limited
About KML Pharmaceuticals Private Limited
Data last updated:
KML Pharmaceuticals Private Limited is a private limited company based in Samastipur, Bihar, India. It operates in the service-based operations segment of the business services sector. It was incorporated on 27 February 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Patna, under CIN U74999BR2017PTC033818.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Lalita Kumari and Manoj Kumar.
Its last annual general meeting (AGM) was held on 30 September 2022, and its latest financial statements are for the year ended 31 March 2022. The registered office is at C/O Manoj Kumar Ward No. 03 Po – Hasanpur Jitwarpur, Samastipur, Bihar, India – 848134.
As per the financials filed for FY 2022, the company reported a revenue of ₹20,000, a growth of 33% compared to the previous year. For the same year it recorded a net loss of ₹283 (net margin -1.4%) and EBITDA of ₹2,320 (EBITDA margin 11.6%). Revenue has declined at a compounded annual rate (CAGR) of 28% over three years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
KML Pharmaceuticals Private Limited's registered office is in Samastipur, Bihar. Its e-mail address is in the company report.
- Email
- Registered AddressC/O Manoj Kumar Ward No. 03 Po – Hasanpur Jitwarpur, Samastipur, Bihar, India – 848134
- IndustryBusiness Services, Other Services, Miscellaneous Business Activities
To see the full contact details of KML Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of KML Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of KML Pharmaceuticals Private Limited, buy the company report.
Financials of KML Pharmaceuticals Private Limited
FY 2022 filings availableKML Pharmaceuticals Private Limited reported revenue of ₹20,000 (up 33% YoY) for FY 2022.
Compounded Annual Growth Rate (CAGR)
Revenue rose 33% in the latest year, though over three years it has declined at a compounded annual rate (CAGR) of 28%. EBITDA fell 57% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2,320 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹283 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 11.6% | ||||
| Net Profit Margin | -1.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of KML Pharmaceuticals Private Limited, buy the company report.
Board of directors of KML Pharmaceuticals Private Limited
KML Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Lalita Kumari | Director | 15 Apr 2021 | 5 Years 6 Months | Current |
| Manoj Kumar | Director | 27 Feb 2017 | 9 Years 8 Months | Current |
Peer comparison
KML Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Biocius Pharmaceuticals Private Limited | ₹20,469 (FY 2025) | -58.0% | Harinagar, Delhi, India | |||
| Evolife Pharmaceuticals Private Limited | ₹20,060 (FY 2024) | -76.0% | Delhi, India | |||
| KML Pharmaceuticals Private Limitedthis company | ₹20,000 (FY 2022) | -₹283 | -1.4% | 33.0% | Samastipur, Bihar, India | |
| Ayurkalpa Pharmaceuticals (OPC) Private Limited | ₹19,535 (FY 2024) | Hyderabad, Telangana, India |
To see the full peer comparison of KML Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving KML Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for KML Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for KML Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
KML Pharmaceuticals Private Limited has 3 board changes on record since 2017: 2 appointments and 1 cessation. The latest: Krishna Kumar ceased to be Director on 16 Apr 2021.
Frequently asked questions
KML Pharmaceuticals is an active private limited company based in Samastipur, Bihar, India. The company works in other services, within the business services industry. It was incorporated on 27 February 2017 (9+ years old) and is registered under CIN U74999BR2017PTC033818.
KML Pharmaceuticals has 2 current directors:
- Lalita Kumari - Director
- Manoj Kumar - Director
The latest financial statements of KML Pharmaceuticals on record with the MCA are for the year ended 31 March 2022. Its last annual general meeting was held on 30 September 2022. Year-wise statements from FY 2017 are in the company report.
The CIN (Corporate Identification Number) of KML Pharmaceuticals is U74999BR2017PTC033818. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
KML Pharmaceuticals was incorporated on 27 February 2017, making it 9+ years old. It is registered with the Registrar of Companies, Patna.
The peers of KML Pharmaceuticals by revenue are Biocius Pharmaceuticals Private Limited, Evolife Pharmaceuticals Private Limited, Ayurkalpa Pharmaceuticals (OPC) Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Krishna Kumar ceased to be Director on 16 Apr 2021. Lalita Kumari was appointed as Director on 15 Apr 2021. Manoj Kumar was appointed as Director on 27 Feb 2017.
The registered office of KML Pharmaceuticals is at CO Manoj Kumar Ward No. 03 Po – Hasanpur Jitwarpur, Samastipur, Bihar, India – 848134.
KML Pharmaceuticals operates in the business services industry, in the other services segment.
The compliance status of KML Pharmaceuticals is compliant as of 19 July 2026. The company is actively filing with the Registrar of Companies.
KML Pharmaceuticals can be reached at its registered office: CO Manoj Kumar Ward No. 03 Po – Hasanpur Jitwarpur, Samastipur, Bihar, India – 848134.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
